Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine

EINECS 1592732-453-0
CAS No. 3159-07-7 Density 1.292 g/cm3
PSA 54.40000 LogP 3.54150
Solubility Melting Point 265 °C
Formula C13H9NOS Boiling Point 309.2 °C at 760 mmHg
Molecular Weight 227.28 Flash Point 140.8 °C
Transport Information Appearance off-white powder
Safety 26-36/37/39 Risk Codes 36/37/38
Molecular Structure Molecular Structure of 3159-07-7 (10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine) Hazard Symbols
Synonyms

10,11-Dihydrodibenzo[b,f][1,4]thiazepin-11-one;Dibenzo[b,f][1,4]thiazepine-11(10-H)-one;NSC 653252;

 

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine Synthetic route

13739-55-4

2-phenylthiophenyl isocyanate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
aluminum (III) chloride In 1,2-dichloro-benzene at 100 - 150℃; for 4h;100%
111974-73-3

phenyl [2-(phenylsulphanyl)phenyl]carbamate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With methanesulfonic acid; phosphorus pentoxide at 80 - 110℃; for 2.5h;96%
With polyphosphoric acid Heating;94%
With PPA In water87%
54920-98-8

2-((2-aminophenyl)thio)benzoic acid

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With PPA at 140℃; for 2h;95%
toluene-4-sulfonic acid In ethyl acetate; xylene at 125℃; for 10h;86%
With phosphorus pentoxide; xylene
32315-10-9

bis(trichloromethyl) carbonate

6764-13-2

2-aminodiphenyl sulfide hydrochloride

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate; 2-aminodiphenyl sulfide hydrochloride In chloroform for 10h; Reflux; Large scale;
Stage #2: With toluene-4-sulfonic acid In chloroform at 120℃; for 3h; Large scale;
93.7%
4892-03-9

methyl 2-(2-nitrophenylthio)[14C]benzoate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With acetic acid; zinc Reagent/catalyst; Reflux;93.4%
Stage #1: methyl 2-(2-nitrophenylthio)[14C]benzoate With tin(II) chloride dihdyrate In ethanol
Stage #2: With trimethylaluminum In dichloromethane at 45 - 100℃;
40%
Multi-step reaction with 2 steps
1: ethyl acetate; Raney nickel / Hydrogenation
2: 220 °C
View Scheme
Multi-step reaction with 2 steps
1: Raney nickel; ethanol / Hydrogenation
2: 220 °C
View Scheme
Multi-step reaction with 2 steps
1.1: iron(III) chloride; pyrographite / 0.5 h / 65 °C
1.2: 12 h / 65 °C
2.1: sodium methylate / toluene / 24 h / 110 °C
View Scheme

benzyl 2-(2-nitrophenylthio)benzoate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 1500.15 Torr; Reagent/catalyst;85.4%
20169-45-3

9H-thioxanthen-9-one oxime

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene Reagent/catalyst; Solvent; Reflux;81.5%
With phosphorus pentachloride In diethyl ether Ambient temperature;
100866-62-4

2-(2-nitrophenylthio)benzoic acid methyl ester

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium methylate In toluene at 110℃; for 24h; Temperature; Reagent/catalyst;80.1%
With acetic acid at 135℃;72%
at 220℃;

2-(2-aminophenylthio)benzoic acid ethyl ester

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium methylate In toluene at 110℃; for 24h;79.6%
201230-82-2

carbon monoxide

63107-77-7

(2-aminophenyl)-2’-bromophenyl sulfide

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With dmap; bis(dibenzylideneacetone)-palladium(0); catacxium A In toluene at 100℃; for 18h; Sealed tube;76%
615-43-0

2-iodophenylamine

4892-02-8

Methyl thiosalicylate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With rongalite; sodium hydroxide In dimethyl sulfoxide at 90℃; for 48h; Inert atmosphere; Schlenk technique; Sealed tube;70%
1134-94-7

2-phenylsulfanyl-aniline

1885-14-9

phenyl chloroformate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium carbonate In toluene62%
610-97-9

o-iodo-methyl-benzoic acid

137-07-5

2-amino-benzenethiol

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With copper(II) ferrite; potassium tert-butylate In N,N-dimethyl-formamide for 24h; Reflux; Inert atmosphere;60%
155882-74-9

2-(2-trifluoroacetylaminophenylthio)benzoic acid

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With trifluoroacetic anhydride In N,N-dimethyl-formamide 1.) reflux, 1 h, 2.) RT, overnight;55%
19806-43-0

2‑(2‑nitrophenylsulfanyl)benzoic acid

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With tributylphosphine at 140℃; for 48h; Schlenk technique; regioselective reaction;51%
Multi-step reaction with 2 steps
1: ethyl acetate
2: triethylamine; benzotriazol-1-ol / dichloromethane
View Scheme
Multi-step reaction with 2 steps
1: hydrogen; palladium on activated charcoal / ethyl acetate / 20 °C
2: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol; triethylamine / dichloromethane / 12 h / 20 °C
View Scheme
2527-03-9

2-phenyl-1,2-benzisothiazolin-3-one

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
In tert-butyl alcohol for 2h; Irradiation;31%
In tert-butyl alcohol for 1.5h; Irradiation;31%
6298-19-7

2-chloro-3-aminopyridine

147-93-3

Thiosalicylic acid

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
In 1,2-dichloro-benzene for 0.8h; Reflux;26%
2527-03-9

2-phenyl-1,2-benzisothiazolin-3-one

A

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

B

2-phenyl-1,2-benzisothiazol-3(2H)-one 1-oxide

Conditions
ConditionsYield
With oxygen In benzene for 2h; Product distribution; Irradiation; other solvents; without oxygen.;A 15%
B 8%
With N-chloro-succinimide; potassium hydrogencarbonate 1) CH2Cl2, 0 deg C, 20 min; 2) water, 1 h.; Yield given. Multistep reaction;
124-38-9

carbon dioxide

1134-94-7

2-phenylsulfanyl-aniline

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With n-butyllithium 1) ether, room temperature, 30 h, 2) ether; Yield given. Multistep reaction;

2-(2-aminophenylthio)benzoic acid hydrochloride

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dioxane / 18 h / Ambient temperature
2: 55 percent / trifluoroacetic anhydride / dimethylformamide / 1.) reflux, 1 h, 2.) RT, overnight
View Scheme
19602-82-5

2,2'-dithiodibenzoic acid dichloride

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2) bromine; 3) basic alumina
2: 31 percent / 2-methyl-propan-2-ol / 2 h / Irradiation
View Scheme
62-53-3

aniline

ethane-α.β-bis-sulfonic acid chloride

ethane-α.β-bis-sulfonic acid chloride

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2) bromine; 3) basic alumina
2: 31 percent / 2-methyl-propan-2-ol / 2 h / Irradiation
View Scheme
88-73-3

2-Chloronitrobenzene

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: ethyl acetate; Raney nickel / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: Raney nickel; ethanol / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 4 steps
1: sodium hydroxide / dimethyl sulfoxide / 80 °C
2: hydrogen / methanol / 4137.29 Torr
3: sodium carbonate / tetrahydrofuran; water
4: PPA / 100 °C
View Scheme
4892-02-8

Methyl thiosalicylate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: ethyl acetate; Raney nickel / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: Raney nickel; ethanol / Hydrogenation
3: 220 °C
View Scheme
3591-73-9

thioxanthene-9-thione

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydroxylamine
2: PCl5 / diethyl ether / Ambient temperature
View Scheme
88-67-5

2-Iodobenzoic acid

137-07-5

2-amino-benzenethiol

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With potassium hydroxide; copper In water
7664-93-9

sulfuric acid

140425-65-6

2-(2-aminophenylthio)-benzonitrile

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With acetic acid In 5,5-dimethyl-1,3-cyclohexadiene; water
With acetic acid In 5,5-dimethyl-1,3-cyclohexadiene; water
4171-83-9

2-nitrophenyl phenyl sulfide

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogen / methanol / 4137.29 Torr
2: sodium carbonate
3: polyphosphoric acid / Heating
View Scheme
Multi-step reaction with 3 steps
1: hydrogen / methanol / 4137.29 Torr
2: sodium carbonate / tetrahydrofuran; water
3: PPA / 100 °C
View Scheme
Multi-step reaction with 2 steps
1.1: iron / ethanol / 1.5 h / Reflux; Large scale
1.2: 15 °C / pH 1 / Large scale
2.1: chloroform / 10 h / Reflux; Large scale
2.2: Polyphosphoric acid / 3 h / 120 °C / Large scale
View Scheme
Multi-step reaction with 3 steps
1: iron; ammonium chloride / water
2: sodium carbonate / toluene
3: polyphosphoric acid / 8 h / 100 - 105 °C
View Scheme
1134-94-7

2-phenylsulfanyl-aniline

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium carbonate
2: polyphosphoric acid / Heating
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate / tetrahydrofuran; water
2: PPA / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate
2: polyphosphoric acid / 80 - 90 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate / toluene
2: polyphosphoric acid / 8 h / 100 - 105 °C
View Scheme
Multi-step reaction with 2 steps
1.1: toluene / 0.08 h / 4 °C
1.2: 1.5 h / 4 °C
2.1: methanesulfonic acid; phosphorus pentoxide / 2.5 h / 80 - 110 °C
View Scheme
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

13745-86-3

11-chloro-dibenzo[b,f][1,4]thiazepine

Conditions
ConditionsYield
With trichlorophosphate In toluene at 100℃; for 12h; Inert atmosphere;99%
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
110-85-0

piperazine

546-68-9

titanium(IV) isopropylate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

5747-48-8

11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine

B

67-63-0

isopropyl alcohol

Conditions
ConditionsYield
at 170℃; for 5h; Heating / reflux;A 99%
B n/a
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

1176987-11-3

C13H10N2S*ClH

Conditions
ConditionsYield
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-[2-(1-piperazinyl)ethoxy]ethanol dihydrochloride monohydrate

110-17-8

(2E)-but-2-enedioic acid

11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine hemifumarate salt

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With N,N-dimethyl-aniline; trichlorophosphate In chlorobenzene at 15 - 100℃; for 3h;
Stage #2: 2-[2-(1-piperazinyl)ethoxy]ethanol dihydrochloride monohydrate With sodium carbonate In dimethyl sulfoxide; chlorobenzene at 85 - 90℃; for 6 - 8h;
Stage #3: (2E)-but-2-enedioic acid In ethyl acetate at 0 - 62℃; for 2.5h; Product distribution / selectivity;
93%
103-76-4

1-(2-hydroxyethyl)piperazine

546-68-9

titanium(IV) isopropylate

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

329216-67-3

O-Dealkyl Quetiapine

B

67-63-0

isopropyl alcohol

Conditions
ConditionsYield
at 170℃; for 5.5h; Heating / reflux;A 91%
B n/a
110-85-0

piperazine

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

753475-15-9

11-piperazin-1-yldibenzo[b,f][1,4]thiazepine hydrochloride

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With trichlorophosphate In toluene at 10℃; for 4h; Heating / reflux;
Stage #2: With potassium carbonate In water; toluene at 15℃;
Stage #3: piperazine With hydrogenchloride more than 3 stages;
90%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

494-20-2

10,11-Dihydrodibenz[b,f][1,4]thiazepine

Conditions
ConditionsYield
With tris(2,4-pentanedionato)ruthenium(III); ytterbium(III) trifluoromethanesulfonate nonohydrate; hydrogen; [2-((diphenylphospino)methyl)-2-methyl-1,3-propanediyl]bis[diphenylphosphine] In tetrahydrofuran at 150℃; under 3750.38 Torr; for 15h; Autoclave;87%
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With hydrazine hydrate In ethylene glycol at 80℃; for 2h;
Stage #2: With potassium hydroxide In water for 2h; Reflux;
74%
With lithium aluminium tetrahydride
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

16634-82-5

N-(p-tolyl)-2-chloroacetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: N-(p-tolyl)-2-chloroacetamide In N,N-dimethyl-formamide at -5 - 30℃;
83%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

138681-35-3

chloro-acetic acid-(2,6-dichloro-4-nitro-anilide)

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(2,6-dichloro-4-nitrophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: chloro-acetic acid-(2,6-dichloro-4-nitro-anilide) In N,N-dimethyl-formamide at -5 - 30℃;
82%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2564-05-8

2-chloro-N-(3-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-chlorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(3-chlorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
82%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

96-32-2

bromoacetic acid methyl ester

1073181-74-4

(11-oxo-11H-dibenzo[b,f][1,4]thiazepin-10-yl)acetic acid methyl ester

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at 60℃; for 0.166667h; Inert atmosphere;
Stage #2: bromoacetic acid methyl ester In N,N-dimethyl-formamide; mineral oil at 80℃; for 5h; Inert atmosphere;
79%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

351-04-2

2-chloro-N-(4-fluorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-fluorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-fluorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

33560-47-3

2-chloro-N-(2,3-dichiorophenyl) acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(2,3-dichiorophenyl) acetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methoxyphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: N-(4-methoxyphenyl)-2-chloroacetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

3289-75-6

2-chloro-N-(4-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-chlorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-chlorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
76%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

38283-38-4

4-(2-chloroacetamido)acetophenone

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-acetylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 4-(2-chloroacetamido)acetophenone In N,N-dimethyl-formamide at -5 - 30℃;
76%
546-68-9

titanium(IV) isopropylate

13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

67-63-0

isopropyl alcohol

B

111974-72-2

quetiapine fumarate

Conditions
ConditionsYield
With pentan-1-ol at 160℃; for 32h; Product distribution / selectivity; Heating / reflux;A n/a
B 75%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

32428-61-8

2-chloro-N-(3-methylphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-methylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(3-methylphenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
74%
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

17329-87-2

2-chloro-N-(4-nitro-phenyl)-acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-nitrophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-nitro-phenyl)-acetamide In N,N-dimethyl-formamide at -5 - 30℃;
74%

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine Chemical Properties

Molecular structure of 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine (CAS NO.3159-07-7) is:

Product Name: 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
CAS Registry Number: 3159-07-7
Empirical Formula: C13H9NOS
Molecular Weight: 227.2817
Melting Point: 265 °C
Surface Tension: 51.1 dyne/cm
Density: 1.292 g/cm3
Flash Point: 140.8 °C
Enthalpy of Vaporization: 55 kJ/mol
Boiling Point: 309.2 °C at 760 mmHg
Vapour Pressure: 0.000647 mmHg at 25°C
Storage temp.: Refrigerator
Product Categories: Pharmaceutical Intermediates;API intermediates;(intermediate of quetiapine fumarate);Intermediates of Quetiapine;Heterocycles

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine Safety Profile

Safty information about 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine (CAS NO.3159-07-7) is:
Risk Statements: 36/37/38 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37/39 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine Specification

 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine , its cas register number is 3159-07-7. It also can be called 10,11-Dihydro-11-oxodibenz[b,f][1,4]thiazepine ; 11-Oxo-10,11-dihydro-Dibenzo[b,f][1,4]thiazepine ; Dibenzo[b,f][1,4]thiazepine-11(10-H)-one .It is a off-white powder.

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields